Description
Pantovis Injection is a proton pump inhibitor formulated with Pantoprazole BP 40 mg, designed for intravenous administration. This sterile lyophilized powder is reconstituted before use, providing fast and effective relief from gastric acid-related disorders. It is indicated for the treatment of gastroesophageal reflux disease (GERD), Zollinger-Ellison syndrome, erosive esophagitis, and other acid-peptic conditions when oral administration is not feasible.
Pantoprazole acts by irreversibly inhibiting the proton pumps in gastric parietal cells, thereby significantly reducing acid secretion. This makes Pantovis a vital therapeutic choice in critical care, postoperative management, and acute episodes of acid hypersecretion. The product is packaged in a single-dose vial, encased in a protective carton to ensure integrity and pharmaceutical-grade sterility.
Manufactured by ANVIS, Pantovis meets international quality standards for hospital-grade injectables. It is suitable for adult patients under medical supervision and forms a reliable part of acid suppression therapy in clinical environments.
